SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD Shanghai Kehua Bio-Engineering Co.,Ltd
Equities
002022
CNE000001KC9
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.89 CNY | +0.58% |
|
-0.14% | -39.46% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Shanghai Kehua Bio-engineering Co., Ltd. specializes in the development, manufacturing and marketing of diagnostic biological products. The group proposes primarily reagents, in vitro diagnostics agents, automated instruments of detection, etc.
China accounts for 91% of net sales.
Calendar
2024-04-28
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -39.46% | 489M | |
| -1.84% | 12.72B | |
| -11.57% | 7.5B | |
| +0.94% | 5.48B | |
| +0.98% | 4.61B | |
| +5.18% | 4.47B | |
| -50.82% | 3.28B | |
| +11.23% | 2.71B | |
| -18.54% | 2.02B | |
| -10.84% | 1.74B |
- Stock Market
- Equities
- 002022 Stock
- News Shanghai Kehua Bio-Engineering Co.,Ltd
- Kehua Bio-Engineering Obtains Clearance to Sell Magnesium Testing Kit in China
